david charles Archives
Deep brain sweet spot might be key to halt Parkinson’s
Jun. 7, 2023—A sweet spot in the deep brain with direct lines of communication to motor regions far out on the cerebral cortex might hold a key to halting the progression of early-stage Parkinson’s disease.
Pilot study suggests Parkinson’s disease progression can be slowed
Jun. 30, 2020—A pair of ultra-thin electrodes surgically implanted deep into the brain might slow the progression of Parkinson’s disease, according to five-year outcomes from a 30-patient randomized clinical trial conducted by investigators at Vanderbilt University Medical Center.
Spasticity underdiagnosed
Mar. 24, 2020—Spasticity — a consequence of stroke and other disorders of the central nervous system — may be underdiagnosed and undertreated in nursing home residents.
Parkinson’s study to track impact of DBS on earliest patients
Aug. 30, 2018—A decade after taking part in the first clinical trial of deep brain stimulation (DBS) administered during very early-stage Parkinson’s disease, participants will return to Vanderbilt University Medical Center this year to be re-evaluated.
VUMC’s membership in NIH NeuroNEXT network renewed
Jul. 26, 2018—The National Institutes of Health (NIH) has renewed Vanderbilt University Medical Center’s membership in NeuroNEXT, a research network that helps streamline Phase 2 clinical trials for brain disorders.
DBS treatment may slow tremor progression in early-stage Parkinson’s patients
Jun. 29, 2018—June 29, 2018 - Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may possibly delay the progression of one of the cardinal features of Parkinson’s disease.
Grant money available for telehealth innovations
Jun. 22, 2017—Grant money is available to the Vanderbilt University Medical Center (VUMC) community in order to support programs that increase ambulatory visits conducted via telemedicine.
Trial to test whether DBS slows Parkinson’s progression
Sep. 1, 2016—A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients.
Telemedicine usage increasing rapidly for many service lines
Aug. 18, 2016—Vanderbilt Heart and Vascular Institute cardiologist Allen Naftilan, M.D., Ph.D., puts a stethoscope to his ears and listens to the heartbeats of patients more than 90 miles away.
Charles represents VUMC at White House Rural Telehealth gathering
Apr. 5, 2016—Last week, David Charles, M.D., chief medical officer of the Vanderbilt Neuroscience Institute, vice-chair of the Department of Neurology and medical director of Telemedicine, represented Vanderbilt University Medical Center at a White House Convening on Rural Telehealth.
Symposium sheds light on potential of telemedicine
Aug. 27, 2015—For patients suffering from a stroke, the key to a positive outcome often hinges on how quickly they can receive a brain-saving medical intervention.
CNS program now giving residents lab experience
Sep. 4, 2014—In the same way scientists from the Vanderbilt Clinical Neuroscience Scholars (CNS) Program have benefited from their experiences in the clinical setting, an initiative is underway for Psychiatry, Neurology and Neurosurgery residents to have an opportunity to do bench work in the basic science labs.